The Active Placebo Effect: Patent Eligible Subject Matter?

Last week President Barack Obama asked a bioethics committee to review federal guidelines for the use of human subjects in medical testing. This announcement came in the wake of revelations that the U.S. sponsored experiments in Guatemala the 1940s where people were intentionally infected with sexually transmitted diseases like syphilis and gonorrhea without their consent .  Several ethical concerns are raised by human clinical trials, including the use of placebos. A common feature of modern Continue Reading →

Labeling Milk from Cows Not Treated with rBST: Legal in all 50 States as of September 29th, 2010

Under the Food, Drug and Cosmetic Act and accompanying regulations, the Food and Drug Administration (FDA) is charged with promulgating regulations pertaining to food, including the labeling of food. Specifically, FDA must ensure that labels are not false or misleading to consumers. Until earlier this fall, the FDA’s determination that milk from cows treated with artificial growth hormones was the same as milk from untreated cows had never been challenged by a court. In International Continue Reading →